News of Note—NovaVax, GeoVax and more

Here's some other vaccine news of note for this week.

> Looking to take on Sanofi's Fluzone HD, NovaVax is kicking off a phase 1/2 study of its NanoFlu candidate in older adults. Release

> GeoVax reported that its Zika vaccine candidate protected 100% of mice in a lethal challenge. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> CEL-SCI won a $1.5 million grant from the National Institutes of Health to work on a rheumatoid arthritis vaccine candidate. Release

> A team at Oregon State University isolated two proteins as promising candidates for a gonorrhea vaccine. Release

Read more on